Pre-Exposure Prophylaxis (PrEP)
12
1
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
8%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Tshireletso: Safety, Efficacy and Feasibility of Cabotegravir-LA PrEP in a Breastfeeding Population in Botswana
eSTEP: An Integrated mHealth Intervention to Engage High-risk Individuals Along the Full PrEP Care Continuum
A Self-administered PrEP Decisional Aid for Dissemination With HIV Self-test Kits (DASH)
California MEPS Hub
Peer-led Community-based PrEP Delivery Among Youth in Brazil
SIRI Checklist: An Integrated Hospital Model to Optimize HIV Prevention in Persons Who Inject Drugs
Clinical Decision Support for PrEP
Impact of Nursing Involvement on Implementation of HIV Prevention Services
Filling Gaps in the HIV Pre-exposure Prophylaxis Cascade Through Counseling
Pre-exposure Prophylaxis (PrEP) Rapid Access
PrEPared-RN, CAN Nurse-Led Management of High-risk Patients for Pre-Exposure Prophylaxis (PrEP)
A Study Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM and TGW